BTG3 and systemic sclerosis: In addition, in the second dataset GSE19617, the expression of BTG3, CCR2, RAB10, and TMEM60 (all P < 0.05) was also considerably up-regulated or down-regulated in the SSc-PAH patients (Figures 3(e)–3(h)).